April 23, 2025

Dry Eye Treatment May Quell Migraine Severity

Longer and larger studies are still needed for a full picture of connections between the conditions

Conexiant

April 23, 2025

AI Model Shows High Specificity and Sensitivity in DR Screening

Researchers urge developers for AI algorithms to monitor and publish their clinical performance for patient safety

Conexiant

April 23, 2025

New Tool Offers Practical Visual Perception Screening for Stroke Survivors

“Existing tests are not always feasible to complete at the acute stage because of their length, reliance on verbal communication, or cumbersome testing materials that make it difficult to complete at bedside.”

Conexiant

April 22, 2025

Improved Outlook for Eye Cancer Diagnostics

Digital biobank aims to improve early detection of rare ocular cancers

The Pathologist

April 18, 2025

Retinal Imaging Captures Alzheimer’s and Dementia Risk

The noninvasive, accessible, and scalable modality can predict risk before disease endpoints can be observed.

Conexiant

April 18, 2025

Glaucomatous Progression in 1 in 4 Patients With Myopia

Patients with a family history of glaucoma were more likely to experience progression or RNFL thinning

Conexiant

April 17, 2025

FDA Reviews Eylea HD for RVO

The agency has initiated priority review of the anti-VEGF agent as a treatment for macular edema secondary to retinal vein occlusion.

Ophthalmology Management

April 17, 2025

Accuracy of AI-Based Retinal Photographic CVD Risk Assessment

Predictive accuracy of the tool was comparable to the traditional WHO assessment for 10-year CVD events.

Conexiant

April 16, 2025

Biocon, Regeneron Reach Agreement on Eylea Biosimilar

The agreement clears the way for Yesafili, an FDA-approved aflibercept biosimilar, to be commercialized in the United States.

Retinal Physician